Copyright
©The Author(s) 2023.
World J Gastroenterol. Jul 21, 2023; 29(27): 4236-4251
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4236
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4236
Figure 1 Simplified diagram of gut-muscle axis disorders in patients with cirrhosis.
LPS: Lipopolysaccharide; PAMP: Pathogen-associated molecular patterns.
Figure 2
Proposed mechanisms of action of drugs targeting the gut-muscle axis in cirrhosis.
- Citation: Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World J Gastroenterol 2023; 29(27): 4236-4251
- URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4236.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i27.4236